UBS Group’s Enveric Biosciences ENVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.1K | Sell |
|
|||||
|
2025
Q1 | $59.4K | Buy |
|
|||||
|
2024
Q4 | $28.1K | Buy |
|
|||||
|
2024
Q3 | $346 | Sell |
|
|||||
|
2024
Q2 | $27.3K | Buy |
|
|||||
|
2024
Q1 | $4.98K | Buy |
|
|||||
|
2023
Q4 | $13 | Sell |
|
|||||
|
2023
Q3 | $740 | Buy |
|
|||||
|
2023
Q2 | $182 | Sell |
|
|||||
|
2023
Q1 | $8.85K | Buy |
|
|||||
|
2022
Q4 | $5K | Sell |
|
|||||
|
2022
Q3 | $22K | Buy |
|
|||||
|
2022
Q2 | $0 | Sell |
|
|||||
|
2022
Q1 | $32K | Buy |
|
|||||
|
2021
Q4 | $13K | Buy |
|
|||||
|
2021
Q3 | $1K | Sell |
|
|||||
|
2021
Q2 | $160K | Buy |
|
|||||
|
2021
Q1 | $97K | Buy |
|
|||||
|
2020
Q3 | – | Hold |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $5K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $9K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $18K | Buy |
|
|||||
|
2018
Q4 | – | Hold |
|
|||||
|
2018
Q3 | – | Hold |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2018
Q1 | – | Hold |
|
|||||
|
2017
Q4 | – | Hold |
|